Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease

Current Medical Research and Opinion

Volumn 23, Issue 9, 2007, Pages 2083-2091

  Hardten, David R ^a   Brown, Marlane J ^a   Pham Vang, Sandy ^a  

^a MINNESOTA EYE CONSULTANTS   (United States)

Author keywords

Cyclosporine; Dry eye; Optive; Restasis

Indexed keywords

ARTIFICIAL TEAR; CARBOXYMETHYLCELLULOSE; CYCLOSPORIN; CYCLOSPORIN A; DYE; ISOTONIC SOLUTION; OPTIVE; REFRESH; REFRESH ENDURA; SYSTANE; UNCLASSIFIED DRUG; EYE DROPS;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY EYE; EYE DISCOMFORT; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT SATISFACTION; QUESTIONNAIRE; SCORING SYSTEM; TEAR FLOW; AGED; CORNEA EPITHELIUM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; XEROPHTHALMIA;

ADMINISTRATION, TOPICAL; AGED; CYCLOSPORINE; EPITHELIUM, CORNEAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; XEROPHTHALMIA;

EID: 36048970088     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X219670     Document Type: Article

References (19)

1. Gilbard JP. Dry eye, blepharitis and chronic eye irritation: divide and conquer. J Ophthalmic Nurs Technol 1999;18: 109-15
2. Bron AJ. Diagnosis of dry eye. Surv Ophthalmol 2001;45 (Suppl 2):S221-S226
3. Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to Optometric practices across Canada. Optom Vis Sci 1997;74:624-31
4. Schirra F, Ruprecht KW. Dry eye. An update on epidemiology, diagnosis, therapy and new concepts. Ophthalmologe 2004;101:10-8
5. Perry HD, Donnenfeld ED. Topical 0.05% cyclosporine in the treatment of dry eye. Expert Opin Pharmacother 2004;5: 2099-107
6. Moss Se, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8
7. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900-7
8. Sun J, Liu C, Zhang Y, Ang H. Effect of cyclosporine A eye drop on keratoconjunctivitis sicca and its mechanism. J Huazhong Univ Sci Technolog Med Sci 2005;25:738-40
9. Sali K, Stevenson OD, Mundorf TK, Reis BL; the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 2000;107:631-9
10. Data on file. Internal File Number 5124277. Allergan, Irvine, CA
11. Horio M, Ito A, Matsuoka Y, et al. Apoptosis induced by hypertonicity in Madin Darley canine kidney cells: protective effect of betaine. Nephrol Dial Transplant 2001;16:483-90
12. Alfieri RR, Cavazzoni A, Petronini PG, et al. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 2002;540:499-508
13. deZengotita VM, Abston LR, Schmelzer AE, et al. Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality. Biotechnol Bioeng 2002;78: 741-52
14. Simmons PA, Garret Q, Xu S, et al. Interaction of carboxymethylcellulose with human corneal cells. Presented at: the annual meeting of the Association for Research in Vision and Ophthalmology, April 30-May 4, 2006; Ft. Lauderdale, FL. Program No. 2759
15. Hunt G, Kearney P, Kellaway IW. Mucoadhesive polymers in drug delivery systems. In: Johnson P, Lloyd-Jones JG, editors. Drug delivery systems: fundamentals and techniques. New York (NY]: VCH Publ. Inc; 1987. p. 180-98
16. Sall KN, Cohen SM, Christensen MT, Stein JM. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens 2006;32:21-6
17. Noecker RJ. Comparison of initial treatment response to two enhanced-viscosity artificial tears. Eye Contact Lens 2006;32:148-52
18. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolality: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006;47:4309-15
19. McCulley JP, Aronowicz JD, Uchiyama E, et al. Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact. Am J Ophthalmol 2006;141:758-60